Sir,
We read with interest the report 'Characterization of damage in Portuguese lupus patients: analysis of a national lupus registry' 1 and wish to emphasize that the frequency and cumulative damage score present in a lupus patient population is also determined by the type of organ damage.
In the registry study of 976 patients by Gonc¸alves et al., 1 the average SDI score was 0.71 AE 1.22 and the frequency of damage was 37.4% after a 17 AE 9.4 year follow-up. This was considered by the authors to be lower in Portuguese patients when compared to other series, namely the University College London Hospital (UCLH) cohort which reported 50% damage at 10 year follow-up 2 and the SLICC cohort, which observed 51% damage at six years follow-up. 3 Of note, in the UCLH cohort, when measured between 15 and 20 years of follow-up, most of the damage accrual occurred in the musculoskeletal system.
A recent retrospective study of our single-centre hospital-based cohort consisting of 98 Portuguese lupus patients, in which every patient was clinically evaluated at the time of study completion, revealed a similar frequency of accrued damage equally measured by SDI values !1. 4 In comparison, although our cohort comprised a similar frequency of articular disease (approximately 70%), there was a higher frequency of neuropsychiatric (NP) disease (22%) than in the national register (11%). In addition, in our cohort, the patients with damage were enriched for NP disease (n ¼ 16/22, 72%) versus non-NP patients (n ¼ 17/76, 22%). Our average SDI scores were higher: 2.31 AE 1.25 for the NP and 1.53 AE 0.80 for the non-NP group. This difference was statistically significant (P ¼ 0, 0001) and was largely due to damage of the neurologic system that occurred in 14 of the 16 NP patients. Both NP and non-NP patients had a similar mean age and disease duration (age: 44 AE 12 and 45 AE 14 years, disease duration: 13 AE 7 and 13 AE 8 years, respectively). SDI scores increased with the duration of the disease in both groups, and were initially 0.44 AE 0.89 for NP and 0 for non-NP patients.
It is well conceivable that Lupus patients with a predominant articular phenotype should have low damage accrual after a long follow-up. However, this is a very heterogeneous disease, and this subset of patients is not representative of the overall population of lupus patients, when other clinical phenotypes are taken into consideration.
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